Next Article in Journal
Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?
Next Article in Special Issue
Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae
Previous Article in Journal
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes
Previous Article in Special Issue
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals
 
 
Article

Article Versions Notes

Antibiotics 2024, 13(3), 266; https://doi.org/10.3390/antibiotics13030266
Action Date Notes Link
article xml file uploaded 16 March 2024 09:47 CET Original file -
article xml uploaded. 16 March 2024 09:47 CET Update https://www.mdpi.com/2079-6382/13/3/266/xml
article pdf uploaded. 16 March 2024 09:48 CET Version of Record https://www.mdpi.com/2079-6382/13/3/266/pdf
article html file updated 16 March 2024 09:49 CET Original file https://www.mdpi.com/2079-6382/13/3/266/html
Back to TopTop